VIDEO: Specialist speaks about her experience with new Xen implant in European trial

Issue: March 2020

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

MARRAKECH, Morocco — At the European Society of Cataract and Refractive Surgeons Winter Meeting, Simonetta Morselli, MD, shares her experience with the Xen gel stent (Allergan). She is one of the investigators in a European study evaluating the safety and efficacy of the new Xen 63 and explains what differentiates this option from the previous Xen 45.